Singapore: Denmark-based Lundbeck and Japanese company Otsuka Pharmaceutical have signed a license and development agree...
Singapore: Takeda Pharmaceutical has recieved Food and Drug Administration (FDA) approval for a new biologic therapy, En...
Singapore: The PGA Tour and subsidiary of Tokyo-based Astellas Pharma launched its first 'Astellas Presents Executive Wo...
Singapore: US-based ArQule and Japanese Daiichi Sankyo have completed the recruitment of patients for their randomized, ...
Singapore: Certara, leading provider of software and scientific consulting services to improve productivity and decisio...
Singapore: Chugai Pharmaceutical and Debiopharm Group entered into a licensing agreement regarding FF284 (called Debio ...
Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Part...
Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastr...
Singapore: Noven Pharmaceuticals, a wholly-owned subsidiary of Japanese firm Hisamitsu Pharmaceutical, has submitted a n...
Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in cert...
Singapore: Japan's Meiji Seika Pharma is set to acquire Bangalore-based generic drug maker Medreich for $290 million. Th...
Singapore: Even as a new strain of stomach flu is infecting many across the world, scientists in Japan seem to have made...
Singapore: Eisai announced that the US Food and Drug Administration (FDA) has approved ACIPHEX Sprinkle Delayed-Releas...
Singapore: Takeda Pharmaceutical has established the Global Medical Affairs Japan Department at Takeda Development Cente...
Singapore: Zeria Pharmaceutical and Astellas Pharma announced that, Zeria has obtained the marketing approval of Acofid...
International pharmaceutical R&D and manufacturing conference and expo, the 25th Interphex Japan, concluded on a suc...
Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery pro...
Singapore: The Shimadzu Global Pharma Summit 2012 held in Singapore sent out an unaninmous message that it is high time ...
Singapore: Scotland's health technology assessment body, Scottish Medicines Consortium (SMC), has approved Eisai's AMPA ...
Singapore: Japanese drugmaker Daiichi Sankyo, which currently holds a majority stake in Ranbaxy, had earlier highlighted...
Singapore: Japan-based global analytics technology provider, Shimadzu, has launched i-Series of new industry standard HP...
Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial c...
Singapore: UCL (University College London) and Japan based Takeda Pharmaceutical have formed a new research collaboratio...
Singapore: Canadian company Opsens signed its first major agreement granting distribution and other rights for its OptoW...
Singapore: A*STAR's Institute for Infocomm Research (I2R), and Topcon Corporation, Japan based ophthalmic instruments an...
Singapore: Omron Healthcare has launched a new wireless sleep monitoring device in Japan that uses ResMed's technology a...
Singapore: Otsuka Pharmaceutical and H Lundbeck announced the US Food and Drug Administration (FDA) has approved ABILIF...
Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year d...
Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter...
Singapore: Takeda Pharmaceutical announced the appointment of new senior leadership as well as the establishment of a ne...
Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combina...
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, has received approval for a key patent by...
Singapore: LG Life Sciences (LGLS) and Mochida Pharmaceutical have finalized the agreement to collaborate during the c...
Japan, like all other developed markets, is facing the crunch of a slowing pharma industry. Furthermore, the pharma situ...
Singapore: The new mobile integrated EMR technology, developed by Fujitsu, a Japanese multinational information technolo...
Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operati...
Singapore: Eisai, US, subsidiary of Tokyo-based Eisai, has appointed Mr Yuji Matsue as chairman and chief executive offi...
Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief fi...
Singapore: Japan-based Eisai has filed two products, Halaven (eribulin) for metastatic breast cancer and Fycompa (peramp...
Singapore: Otsuka Pharmaceutical and H Lundbeck's submission of a marketing authorization application (MAA) for the app...
Singapore: Santen, a wholly owned subsidiary of Japan-based Santen Pharmaceuticals, and Clearside Biomedical, announced...
Singapore: India based information technology, consulting and outsourcing company, Wipro, has partenerd with Japan's Tak...
Singapore: Affymax and Takeda Pharma decided to voluntarily recall all lots of Omontys (peginesatide) injection to the u...
Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...
Singapore: The European Medicines Agency has accepted a marketing authorization application for alogliptin, a selective ...
Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...
Singapore: Australian infectious disease therapy development company BioDiem has been granted a key Japanese patent for...
Singapore: Zecotek Photonics, a developer of leading-edge photonics technologies for medical, industrial and scientific ...
Singapore: Israel-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, has announced receiving two a...
Singapore: Novo Nordisk announced that the Japanese Ministry of Health, Labour and Welfare has approved Ryzodeg (insu...
Singapore: Japanese company Mitsubishi Tanabe Pharma and Canada-based Cytochroma have terminated a license agreement exe...
When the Indian generic sector forayed into the global arena almost two decades back, the affordability of its treatment...
Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...
Singapore: ReproCELL, a Japanese stem cell technology company, has opened the company's first branch and US office in Bo...
Singapore: Japanese pharmaceutical company Kyowa Hakko Kirin temporarily suspended patient enrollment in an internationa...
Singapore: "BIOtech 2013 in Japan", which recorded significant growth both in the scale and the quality, concluded in hu...
Singapore: A large-scale retrospective database analysis on atorvastatin (Lipitor) by Astellas Pharma and Pfizer Japan h...
Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...
Singapore: The Indian Department of Commerce is showcasing the achievement of the country's pharmaceutical sector at the...
Singapore: In order to speed up the approval process for medical devices, Japan is planning to introduce some changes in...
Singapore: The Jikei University School of Medicine has become the second Japanese university to find that clinical data ...
Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protei...
Singapore: Dr Takeshi Yura has been promoted by AMRI to the position of vice president of discovery and development serv...
Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will gr...
Singapore: Medtronic started Symplicity HTN-Japan, the first clinical trial with the Symplicity renal denervation system...
Singapore: Bristol-Myers Squibb and Pfizer announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has...
Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Ch...
Singapore: Biosensors International, a developer, manufacturer and marketer of innovative medical devices, is collaborat...
Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Healt...
Singapore: Osaka-based Shionogi has began to supply Pirespa 200mg tablet (pirfenidone) to Ildong Pharmaceutical, which i...
TriReme Medical, a US-based start-up medical devices company dedicated to the development and manufacturing of innovativ...
Singapore: Sucampo Pharma and Abbott received approval from the Ministry of Health, Labor and Welfare, Japan for AMITIZA...
Singapore: Japan-based Otsuka Pharmaceutical launched a newly designed English corporate website in collaboration with a...
Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 di...
Singapore: Japanese scientists are skeptical about the country's new strategy for economic growth, which includes an emp...
Singapore: In an effort to speedup business expansion in emerging nations, Japan's largest drug maker, Takeda Pharmaceut...
Cambridge, Massachusetts: Lorcaserin, a chemical drug that aims to control obesity by altering the serotonin receptors i...
Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan...
Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is em...
Singapore: Eisai has signed an agreement with Epizyme and Roche Molecular Systems to collaborate on the development of ...
Singapore: Takeda Pharmaceutical and H Lundbeck will be presenting new data from four studies that evaluated effectivene...
Singapore: Japan Vaccine, a joint venture created by equal investments from Daiichi Sankyo and GlaxoSmithKline, started ...
Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (gene...
Singapore: Mitsubishi Electric to supply its proton beam therapy system for cancer treatment to Tsuyama Chuo Hospital, J...
Singapore: Edwards Lifesciences, makers of heart valves and hemodynamic monitoring, has announced that Japan's Central S...
Singapore: Japanese drugmaker Mitsubishi Tanabe Pharma Corporation (MTPC) and Canada-based Medicago, a clinical-stage bi...
Singapore: Bionest Partners and Scisive Consulting have merged to form a global strategy and management consulting firms...
Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be c...
Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It te...
Singapore: Astellas Pharma and MSD KK, the Japan unit of US pharma giant Merck, have entered into a co-promotion agreeme...
Singapore: CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process d...
Singapore: Eisai will launch the tablet-type Bi Chocola Collagen and gelée drink-type Bi Chocola Collagen Gelée (...
Singapore: Astellas Pharma and UCB announced that UCB Japan has received marketing approval from the Japanese Ministry ...
Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, ant...
Singapore: Mr Marty Golden will be joining Astellas as the new vice president of Government Affairs with effect from Jul...
Singapore: Sucampo Pharmaceuticals and Abbott have launched Amitiza (lubiprostone) in Japan, a prescription medicine for...
Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...
Singapore: Swiss-based Vifor Pharma, a company of the Galenica Group, has entered into an exclusive licensing agreement ...
Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has ...
Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, fr...
